Literature DB >> 12228163

Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

L Danks1, A Sabokbar, R Gundle, N A Athanasou.   

Abstract

BACKGROUND: Pathological bone resorption (marginal erosions and juxta-articular osteoporosis) by osteoclasts commonly occurs in rheumatoid arthritis (RA).
OBJECTIVES: To define the nature of the mononuclear precursor cells from which osteoclasts are formed in inflamed synovial tissues and to determine the cellular and humoral factors which influence osteoclast differentiation.
METHOD: Macrophage (CD14+), non-macrophage (CD14-), and unsorted (CD14+/CD14-) synovial cell populations from RA and inflammatory/non-inflammatory osteoarthritis (OA) synovium were cultured in the presence of receptor activator for nuclear factor kappaB ligand (RANKL) and monocyte-colony stimulating factor (M-CSF; in the presence/absence of prostaglandin E(2) (PGE(2)), interleukin 1beta (IL1beta), tumour necrosis factor alpha (TNFalpha), and IL6). Osteoclast differentiation was assessed by expression of tartrate resistant acid phosphatase (TRAP), vitronectin receptor (VNR), and lacunar resorption.
RESULTS: TRAP+ and VNR+ multinucleated cells capable of lacunar resorption were only formed in cultures of CD14+-containing synovial cell populations (that is, CD14+ and CD14+/CD14- cells). No difference in the extent of osteoclast formation was noted in cultures of CD14+ cells isolated from RA, inflammatory OA, and non-inflammatory OA synovium. However, more TRAP+/VNR+ cells and more lacunar resorption was noted in CD14+/CD14- cells from RA and inflammatory OA synovial tissues. The addition of PGE(2), IL1beta, TNFalpha, and IL6 did not increase RANKL/M-CSF-induced osteoclast formation and lacunar resorption of both CD14+/CD14- and CD14+ synovial cell populations.
CONCLUSIONS: Osteoclast precursors in synovial tissues are CD14+ monocyte/macrophages. The increase in osteoclast formation in cultures of CD14+/CD14- compared with CD14+ synovial cells in RA and inflammatory OA points to a role for CD14- cells in promoting osteoclast differentiation and bone resorption in inflamed synovial tissues by a mechanism which does not involve a direct effect of proinflammatory cytokines/prostaglandins on RANKL-induced macrophage-osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228163      PMCID: PMC1753924          DOI: 10.1136/ard.61.10.916

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  48 in total

1.  Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Authors:  J M Quinn; N J Horwood; J Elliott; M T Gillespie; T J Martin
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.

Authors:  S Kotake; N Udagawa; M Hakoda; M Mogi; K Yano; E Tsuda; K Takahashi; T Furuya; S Ishiyama; K J Kim; S Saito; T Nishikawa; N Takahashi; A Togari; T Tomatsu; T Suda; N Kamatani
Journal:  Arthritis Rheum       Date:  2001-05

Review 3.  Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.

Authors:  B B Aggarwal
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 4.  Anti-interleukin 6 receptor antibody treatment in rheumatic disease.

Authors:  N Nishimoto; T Kishimoto; K Yoshizaki
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

Authors:  T Nakashima; Y Kobayashi; S Yamasaki; A Kawakami; K Eguchi; H Sasaki; H Sakai
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

6.  Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis.

Authors:  T Sekine; K Masuko-Hongo; T Matsui; H Asahara; M Takigawa; K Nishioka; T Kato
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

7.  Expression of osteoclast differentiation factor in rheumatoid arthritis.

Authors:  Y Shigeyama; T Pap; P Kunzler; B R Simmen; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  2000-11

8.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

9.  Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.

Authors:  E Jimi; I Nakamura; L T Duong; T Ikebe; N Takahashi; G A Rodan; T Suda
Journal:  Exp Cell Res       Date:  1999-02-25       Impact factor: 3.905

10.  Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.

Authors:  H Brändström; T Björkman; O Ljunggren
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

View more
  30 in total

1.  Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis.

Authors:  Kenji Ogawa; Masaaki Mawatari; Mitsunori Komine; Masamori Shigematsu; Masaru Kitajima; Akiko Kukita; Takao Hotokebuchi
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

Review 2.  Targeting the stromal microenvironment in chronic inflammation.

Authors:  Andrew Filer; Costantino Pitzalis; Christopher D Buckley
Journal:  Curr Opin Pharmacol       Date:  2006-05-08       Impact factor: 5.547

3.  Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts.

Authors:  Kalaivani Ganesan; Chidambaram Balachandran; Bhakthavatsalam Murali Manohar; Rengarajulu Puvanakrishnan
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 4.  Synovial tissue heterogeneity and peripheral blood biomarkers.

Authors:  Serena Bugatti; Antonio Manzo; Michele Bombardieri; Barbara Vitolo; Frances Humby; Stephen Kelly; Carlomaurizio Montecucco; Costantino Pitzalis
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

5.  Stage-dependent suppression of the formation of dentin-resorbing multinuclear cells with migration inhibitory factor in vitro.

Authors:  Takashi Kikuiri; Yoshitaka Yoshimura; Futoshi Tabata; Tomokazu Hasegawa; Jun Nishihira; Tetsuo Shirakawa
Journal:  Exp Ther Med       Date:  2011-10-07       Impact factor: 2.447

6.  Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis.

Authors:  Bindu Varghese; Chrystal Paulos; Philip S Low
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

7.  Structure of macrophage colony stimulating factor bound to FMS: diverse signaling assemblies of class III receptor tyrosine kinases.

Authors:  Xiaoyan Chen; Heli Liu; Pamela J Focia; Ann Hye-Ryong Shim; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

8.  Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.

Authors:  Tiffany J Dickerson; Erika Suzuki; Catherine Stanecki; Hyun-Seock Shin; Hong Qui; Iannis E Adamopoulos
Journal:  J Autoimmun       Date:  2012-08-03       Impact factor: 7.094

9.  Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells.

Authors:  Tomonori Taketa; Akinori Sakai; Shinya Tanaka; Kenichiro Nakai; Kunitaka Menuki; Hirotoshi Yamane; Kazuhiro Tanaka; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

10.  The proliferative human monocyte subpopulation contains osteoclast precursors.

Authors:  Roya Lari; Peter D Kitchener; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2009-02-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.